Quality of Life in Patients With Allergic Rhinitis: Clinical Trial With Bilastine or Loratadine

Exclusion Criteria

• •pregnancy or breast-feeding;
• •non-allergic rhinitis (vasomotor, infectious or drug-induced);
• •known hypersensitivity to antihistamines;
• •clinical disorders that might affect the assessment;
• •nasal diseases that could lead to complete blockage or one of the nostrils blockage, such as tumors or septal deviation;
• •therapy with immunotherapy;
• •use of antihistamines or disodium cromoglycate within the past four weeks;
• •use of topical or systemic corticosteroids, immunosuppressants or any investigational drug within the last two weeks;
• •use of topical antihistamines or nasal decongestants within the last 48 hours;
• •use of deposit steroid within the last month.